Company Filing History:
Years Active: 2025
Title: Chaodi Dai: Innovator in KRAS G12D Modulating Compounds
Introduction
Chaodi Dai is a prominent inventor based in San Mateo, California. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of compounds that target specific mutations in the KRAS gene.
Latest Patents
Chaodi Dai holds a patent for "KRAS G12D modulating compounds." This patent includes compounds and pharmaceutically acceptable salts that are useful as KRAS G12D and/or KRAS G12C inhibitors. The patent outlines methods for making and using these compounds, either alone or in combination with additional agents, as well as the pharmaceutical compositions derived from them.
Career Highlights
Chaodi Dai is currently employed at Gilead Sciences, Inc., where he continues to work on innovative solutions in the pharmaceutical industry. His expertise in modulating compounds has positioned him as a valuable asset in the research and development of targeted therapies.
Collaborations
Chaodi collaborates with Darryl Kato, leveraging their combined expertise to advance their research initiatives.
Conclusion
Chaodi Dai's work in developing KRAS G12D modulating compounds exemplifies the innovative spirit of modern pharmaceutical research. His contributions are paving the way for new therapeutic options in the treatment of diseases associated with KRAS mutations.